293 related articles for article (PubMed ID: 24981012)
1. Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease.
Sanders LH; McCoy J; Hu X; Mastroberardino PG; Dickinson BC; Chang CJ; Chu CT; Van Houten B; Greenamyre JT
Neurobiol Dis; 2014 Oct; 70():214-23. PubMed ID: 24981012
[TBL] [Abstract][Full Text] [Related]
2. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model.
Zharikov AD; Cannon JR; Tapias V; Bai Q; Horowitz MP; Shah V; El Ayadi A; Hastings TG; Greenamyre JT; Burton EA
J Clin Invest; 2015 Jul; 125(7):2721-35. PubMed ID: 26075822
[TBL] [Abstract][Full Text] [Related]
3. Evidence for Compartmentalized Axonal Mitochondrial Biogenesis: Mitochondrial DNA Replication Increases in Distal Axons As an Early Response to Parkinson's Disease-Relevant Stress.
Van Laar VS; Arnold B; Howlett EH; Calderon MJ; St Croix CM; Greenamyre JT; Sanders LH; Berman SB
J Neurosci; 2018 Aug; 38(34):7505-7515. PubMed ID: 30030401
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
5. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
Verma R; Nehru B
Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of toxicity in rotenone models of Parkinson's disease.
Sherer TB; Betarbet R; Testa CM; Seo BB; Richardson JR; Kim JH; Miller GW; Yagi T; Matsuno-Yagi A; Greenamyre JT
J Neurosci; 2003 Nov; 23(34):10756-64. PubMed ID: 14645467
[TBL] [Abstract][Full Text] [Related]
7. VGLUT2 Is a Determinant of Dopamine Neuron Resilience in a Rotenone Model of Dopamine Neurodegeneration.
Buck SA; De Miranda BR; Logan RW; Fish KN; Greenamyre JT; Freyberg Z
J Neurosci; 2021 Jun; 41(22):4937-4947. PubMed ID: 33893220
[TBL] [Abstract][Full Text] [Related]
8. Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson's disease.
Chen Y; Zhang DQ; Liao Z; Wang B; Gong S; Wang C; Zhang MZ; Wang GH; Cai H; Liao FF; Xu JP
Mol Neurodegener; 2015 Mar; 10():4. PubMed ID: 26013581
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial DNA homeostasis is essential for nigrostriatal integrity.
Tzoulis C; Schwarzlmüller T; Biermann M; Haugarvoll K; Bindoff LA
Mitochondrion; 2016 May; 28():33-7. PubMed ID: 26979109
[TBL] [Abstract][Full Text] [Related]
10. Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
Betarbet R; Sherer TB; MacKenzie G; Garcia-Osuna M; Panov AV; Greenamyre JT
Nat Neurosci; 2000 Dec; 3(12):1301-6. PubMed ID: 11100151
[TBL] [Abstract][Full Text] [Related]
11. Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease.
Tapias V; Cannon JR; Greenamyre JT
Neurobiol Aging; 2014 May; 35(5):1162-76. PubMed ID: 24315037
[TBL] [Abstract][Full Text] [Related]
12. Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.
Betarbet R; Canet-Aviles RM; Sherer TB; Mastroberardino PG; McLendon C; Kim JH; Lund S; Na HM; Taylor G; Bence NF; Kopito R; Seo BB; Yagi T; Yagi A; Klinefelter G; Cookson MR; Greenamyre JT
Neurobiol Dis; 2006 May; 22(2):404-20. PubMed ID: 16439141
[TBL] [Abstract][Full Text] [Related]
13. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
14. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
Pinto M; Nissanka N; Moraes CT
J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404
[No Abstract] [Full Text] [Related]
15. Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein.
Subramaniam SR; Vergnes L; Franich NR; Reue K; Chesselet MF
Neurobiol Dis; 2014 Oct; 70():204-13. PubMed ID: 25016198
[TBL] [Abstract][Full Text] [Related]
16. Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease.
Carriere CH; Kang NH; Niles LP
Brain Res; 2016 Feb; 1633():115-125. PubMed ID: 26740407
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders.
Gu G; Reyes PE; Golden GT; Woltjer RL; Hulette C; Montine TJ; Zhang J
J Neuropathol Exp Neurol; 2002 Jul; 61(7):634-9. PubMed ID: 12125742
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models.
Xiong N; Long X; Xiong J; Jia M; Chen C; Huang J; Ghoorah D; Kong X; Lin Z; Wang T
Crit Rev Toxicol; 2012 Aug; 42(7):613-32. PubMed ID: 22574684
[TBL] [Abstract][Full Text] [Related]
19. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT
J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198
[TBL] [Abstract][Full Text] [Related]
20. Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease.
Miyazaki I; Isooka N; Imafuku F; Sun J; Kikuoka R; Furukawa C; Asanuma M
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
